MB - myoglobin Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102132612
MB Products (2)
| mRNA | Protein | Name |
|---|---|---|
| XM_015457261.2 | XP_015312747.1 | myoglobin |
| XM_005567460.3 | XP_005567517.1 | myoglobin |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
myoglobin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B1029 | Danazol | 99.70% | Yes | |
| HY-109523 | Cerivastatin sodium | 99.89% | Unkown | |
| HY-14197 | Clorgyline | Inhibitor | 99.76% | Unkown |
| HY-129458 | Cerivastatin | / | Unkown | |
| HY-B1029R | Danazol (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(13)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-109071 | Relmapirazin | Activator | / | Phase 3 |
| HY-15518 | LCL161 | Inhibitor | 99.91% | Phase 2 |
| HY-11038 | Zelavespib | Inhibitor | 99.93% | Phase 2 |
| HY-101567 | BMS-986158 | Inhibitor | 99.75% | Phase 2 |
| HY-145652 | Narmafotinib | 99.86% | Phase 2 | |
| HY-111288 | MB-07811 | Agonist | 99.75% | Phase 2 |
| HY-14955 | Managlinat dialanetil | Inhibitor | 99.67% | Phase 2 |
| HY-E70007 | Catechol O-methyltransferase, porcine liver | / | Phase 2 | |
| HY-16309 | MB-07803 | Inhibitor | / | Phase 2 |
| HY-109113 | Camsirubicin | Inhibitor | / | Phase 2 |
| HY-178822 | AQ-13 | / | Phase 2 | |
| HY-112842 | MBQ-167 | Inhibitor | 99.85% | Phase 1 |
| HY-10062 | AZD3409 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(414)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0431 | Astragaloside IV | Inhibitor | 99.93% | Unkown |
| HY-139665 | VB124 | Inhibitor | 99.86% | Unkown |
| HY-129039 | Butyrolactone 3 | Inhibitor | 99.58% | Unkown |
| HY-W007465 | 4-Aminobenzyl alcohol | 99.95% | Unkown | |
| HY-12810 | EHop-016 | Inhibitor | 99.38% | Unkown |
| HY-B1816 | Zaprinast | 99.88% | Unkown | |
| HY-153910 | AGPS-IN-1 | 99.74% | Unkown | |
| HY-115467 | MitoBloCK-10 | 98.99% | Unkown | |
| HY-100753 | STAT3-IN-1 | 96.28% | Unkown | |
| HY-16307 | MB05032 | Inhibitor | 99.63% | Unkown |
| HY-N0448 | 10-Gingerol | 99.48% | Unkown | |
| HY-119272 | EF24 | 99.34% | Unkown | |
| HY-15985 | CTX-0294885 | Inhibitor | 99.43% | Unkown |
| HY-13808 | UNC 0631 | Inhibitor | 99.27% | Unkown |
| HY-N1231 | Sophoraflavanone G | Inducer | 99.72% | Unkown |
| HY-Y1045 | Tetrabutylammonium hydrogensulfate | 98.0% | Unkown | |
| HY-148334 | MS8815 | Degrader | 99.95% | Unkown |
| HY-102069 | 3MB-PP1 | Inhibitor | 99.66% | Unkown |
| HY-W111581 | Copper(II) diethyldithiocarbamate | Inducer | 98.5% | Unkown |
| HY-145262 | eIF4E-IN-2 | Inhibitor | 98.91% | Unkown |
| HY-150233 | Cys-McMMAF | Inhibitor | 99.45% | Unkown |
| HY-110243 | CAIX Inhibitor S4 | Inhibitor | 99.04% | Unkown |
| HY-146751 | PI3K/Akt/mTOR-IN-2 | 99.93% | Unkown | |
| HY-173496 | ST6GAL1-IN-1 | Inhibitor | 99.33% | Unkown |
| HY-115903 | HIF-1α-IN-2 | Inhibitor | 98.48% | Unkown |
| HY-11038B | Zelavespib hydrochloride | Inhibitor | 99.25% | Yes |
| HY-13807 | UNC0646 | Inhibitor | 99.38% | Unkown |
| HY-115605 | CN009543V | 99.37% | Unkown | |
| HY-163144 | DAS-5-oCRBN | Degrader | 99.21% | Unkown |
| HY-19513 | MB-07344 | Agonist | 99.86% | Unkown |
| HY-108317 | ABL127 | Inhibitor | 99.91% | Unkown |
| HY-112589 | BRITE-338733 | Inhibitor | 98.93% | Unkown |
| HY-149843 | LC-MB12 | Degrader | 98.10% | Unkown |
| HY-117154 | INH154 | 99.89% | Unkown | |
| HY-164064 | Anticancer agent 230 | Activator | 99.77% | Unkown |
| HY-170620 | PARP1 PROTAC 180055 | Inhibitor | 98.90% | Unkown |
| HY-N8146 | Bruceantinol | Inhibitor | 98.89% | Unkown |
| HY-100353 | C12-Ceramide | 99.82% | Unkown | |
| HY-168929 | SHP1 activator 1 | 99.38% | Unkown | |
| HY-N8187 | Eupalinolide O | Inducer | 99.82% | Unkown |
| HY-132305 | VEGFR-3-IN-1 | Inhibitor | 98.76% | Unkown |
| HY-120373 | MB710 | 98.81% | Unkown | |
| HY-139577A | Ninerafaxstat trihydrochloride | 99.64% | Unkown | |
| HY-108447 | BC-11 hydrobromide | Inhibitor | 99.22% | Unkown |
| HY-114979 | Pyoluteorin | 99.90% | Unkown | |
| HY-129578 | Asperphenamate | 98.0% | Unkown | |
| HY-110329 | ML179 | Agonist | 99.73% | Unkown |
| HY-156278 | FB49 | Inhibitor | 99.76% | Unkown |
| HY-155309 | LM-41 | Inhibitor | 99.87% | Unkown |
| HY-104051 | Monacolin J | Inhibitor | 99.22% | Unkown |
| HY-129163 | HJ-PI01 | Inhibitor | 99.50% | Unkown |
| HY-131763 | 2'-O-MB-cAMP sodium | 99.95% | Unkown | |
| HY-139659 | ARD-61 | 99.57% | Unkown | |
| HY-146324 | PROTAC eEF2K degrader-1 | Activator | 98.64% | Unkown |
| HY-162352 | SDU-071 | Inhibitor | 98.75% | Unkown |
| HY-N0247 | Saikosaponin B1 | Inhibitor | 99.42% | Unkown |
| HY-122658 | MitoBloCK-1 | Inhibitor | 98.87% | Unkown |
| HY-13808R | UNC 0631 (Standard) | Inhibitor | 99.54% | Unkown |
| HY-112338 | C188 | 98.29% | Unkown | |
| HY-155787 | SHR5428 | Inhibitor | 99.80% | Unkown |
| HY-155982 | STAT3-IN-20 | Inhibitor | 99.83% | Unkown |
| HY-162640 | LDR102 | Inhibitor | 99.78% | Unkown |
| HY-179044 | MKK7-JNK activator 1 | 99.89% | Unkown | |
| HY-180261 | GP262 | 98.75% | Unkown | |
| HY-50936S | Trabectedin-d3 | 98.04% | Unkown | |
| HY-N2638 | Ilexsaponin A | Inhibitor | 99.53% | Unkown |
| HY-161456 | PHGDH-IN-5 | Inhibitor | 98.12% | Unkown |
| HY-116447 | Antitumor agent-159 | Inducer | 99.0% | Unkown |
| HY-119257 | ABT-100 | ≥98.0% | Unkown | |
| HY-120275 | CYD-2-11 | 99.92% | Unkown | |
| HY-148368 | CYD-4-61 | 99.92% | Unkown | |
| HY-148452 | eIF4A3-IN-18 | Inhibitor | 99.58% | Unkown |
| HY-151388 | hMAO-B/MB-COMT-IN-1 | Inhibitor | 98.04% | Unkown |
| HY-156096 | HDAC3-IN-2 | / | Unkown | |
| HY-158059 | DS-1-38 | Inhibitor | 99.57% | Unkown |
| HY-158208 | PMMB276 | Inhibitor | 99.81% | Unkown |
| HY-162645 | BPR5K230 | Inhibitor | 99.82% | Unkown |
| HY-168996 | LA-CB1 | 98.20% | Unkown | |
| HY-176165 | CDK9/EZH2-IN-1 | Inhibitor | 99.08% | Unkown |
| HY-178275 | Hydrotecan-NH-L-Ala-L-Val-L-Gln(CO-C5-succinimide)-D-glucitol | 98.26% | Unkown | |
| HY-N0046 | Notoginsenoside Fe | Inhibitor | 99.99% | Unkown |
| HY-N3057 | Pinostrobin chalcone | 99.94% | Unkown | |
| HY-115903A | HIF-1α-IN-2 hydrochloride | Inhibitor | 98.08% | Unkown |
| HY-119331 | CFM-5 | Inducer | 99.48% | Unkown |
| HY-125807 | IS20 | 99.85% | Unkown | |
| HY-143903 | ZL-Pin13 | Inhibitor | 99.87% | Unkown |
| HY-144699 | ERRα antagonist-2 | Antagonist | 99.07% | Unkown |
| HY-148446 | eIF4A3-IN-12 | Inhibitor | 99.70% | Unkown |
| HY-156273 | HDAC/JAK/BRD4-IN-1 | Inhibitor | / | Unkown |
| HY-15985A | CTX-0294885 hydrochloride | 99.73% | Unkown | |
| HY-163676 | MI-217 | 99.52% | Unkown | |
| HY-178367 | PFKFB4-IN-1 | 99.91% | Unkown | |
| HY-N6990 | Anhydrosecoisolariciresinol | 99.94% | Unkown | |
| HY-P2799D | Creatine Kinase MB (rCK-MB), Recombinant Human | / | Unkown | |
| HY-W231513 | MASTL/Aurora A-IN-1 | Inhibitor | 99.47% | Unkown |
| HY-11038D | Zelavespib formic | Inhibitor | 97.39% | Unkown |
| HY-101517A | (S)-PI3K-IN-2 | Inhibitor | 99.50% | Unkown |
| HY-148444 | eIF4A3-IN-10 | Inhibitor | 97.87% | Unkown |
| HY-148445 | eIF4A3-IN-11 | Inhibitor | 99.24% | Unkown |
| HY-148449 | eIF4A3-IN-15 | Inhibitor | / | Unkown |
| HY-148450 | eIF4A3-IN-16 | Inhibitor | 99.96% | Unkown |
| HY-148451 | eIF4A3-IN-17 | Inhibitor | 99.56% | Unkown |
| HY-149636 | Multi-target kinase inhibitor 2 | 99.82% | Unkown | |
| HY-157797 | SN-38-CM2 | Control | / | Unkown |
| HY-158170 | CDK7-IN-28 | Inhibitor | / | Unkown |
| HY-159990 | GPX4-IN-15 | Inhibitor | 98.79% | Unkown |
| HY-161096 | Antitumor agent-127 | 99.09% | Unkown | |
| HY-161446 | USP1-IN-7 | Inhibitor | 99.93% | Unkown |
| HY-161597 | PROTAC DYRK2 degrader 1 | Degrader | / | Unkown |
| HY-162531 | KIF18A-IN-9 | Inhibitor | 95.03% | Unkown |
| HY-162632 | Hit 14 | Inhibitor | ≥99.0% | Unkown |
| HY-163290 | HDAC-MB | Inhibitor | 99.42% | Unkown |
| HY-168093 | Cetzole | Inducer | / | Unkown |
| HY-168969 | AA-BR-157 | 96.47% | Unkown | |
| HY-172562 | BTR2004 | Inhibitor | 99.86% | Unkown |
| HY-175656 | MDI-117740 | Inhibitor | 99.85% | Unkown |
| HY-176549 | (Rac)-IBR120 | Inhibitor | 99.65% | Unkown |
| HY-176713 | KWZY-11 | / | Unkown | |
| HY-178914 | Copper ionophore I | 99.9% | Unkown | |
| HY-19513A | MB-07344 sodium | Agonist | 99.30% | Unkown |
| HY-Z12208 | N1-Phenylsuberamide | 99.43% | Unkown | |
| HY-134395 | 6-MB-cAMP | / | Unkown | |
| HY-160899A | Thailanstatin A cyclohexane diamine formic | 93.74% | Unkown | |
| HY-165421 | Mps1-IN-10 | Inhibitor | 98.20% | Unkown |
| HY-W643128 | Carlina oxide | Inhibitor | / | Unkown |
| HY-144876 | RIDR-PI-103 | Inducer | 98.02% | Unkown |
| HY-107770 | Duocarmycin MB | / | Unkown | |
| HY-115507 | NMac1 | / | Unkown | |
| HY-136289 | MB-VC-MGBA | / | Unkown | |
| HY-178114 | SKLB-0124 | / | Unkown | |
| HY-181035 | DN1679 | Degrader | / | Unkown |
| HY-103043 | Pz 285 | / | Unkown | |
| HY-156403 | AuM1Phe | Inhibitor | / | Unkown |
| HY-101447 | SI-2 | / | Unkown | |
| HY-106159 | SB-T-101141 | Inducer | / | Unkown |
| HY-109523S | Cerivastatin-d3 sodium | / | Unkown | |
| HY-117093 | H8-A5 | Inhibitor | / | Unkown |
| HY-118820 | MB-28767 | Agonist | / | Unkown |
| HY-119408 | MB725 | Activator | / | Unkown |
| HY-120372 | BMS-871 | Inhibitor | / | Unkown |
| HY-120421 | SW116 free base | / | Unkown | |
| HY-120800 | KUNG29 | Inhibitor | / | Unkown |
| HY-123186 | MB-11362 | Inhibitor | / | Unkown |
| HY-123715 | Anticancer agent 255 | / | Unkown | |
| HY-125958 | AA9 | Inhibitor | / | Unkown |
| HY-126005 | VGSC blocker-1 | Inhibitor | / | Unkown |
| HY-131037 | MB-0223 | Inhibitor | / | Unkown |
| HY-131508 | M&B 5124 | Inhibitor | / | Unkown |
| HY-136747 | Nek2/Hec1-IN-1 | / | Unkown | |
| HY-139376 | FGFR1 inhibitor-2 | Inhibitor | / | Unkown |
| HY-143293 | VEGFR-IN-3 | / | Unkown | |
| HY-143468 | MEK-IN-5 | / | Unkown | |
| HY-143877 | NN-390 | Inhibitor | / | Unkown |
| HY-144306 | ERα degrader 4 | / | Unkown | |
| HY-144638 | JMX0293 | / | Unkown | |
| HY-144642 | PARP-1-IN-1 | Inhibitor | / | Unkown |
| HY-145860 | PHGDH-IN-2 | / | Unkown | |
| HY-146037 | Aurora A inhibitor 2 | / | Unkown | |
| HY-146103 | Antiproliferative agent-7 | Inducer | / | Unkown |
| HY-146203 | FAK inhibitor 6 | / | Unkown | |
| HY-146239 | EGFR/HER2/TS-IN-2 | Inhibitor | / | Unkown |
| HY-146283 | LSD1-IN-18 | Inhibitor | / | Unkown |
| HY-146284 | LSD1-IN-19 | Inhibitor | / | Unkown |
| HY-146285 | LSD1-IN-20 | Inhibitor | / | Unkown |
| HY-146452 | Anticancer agent 57 | Inducer | / | Unkown |
| HY-146511 | Anticancer agent 41 | / | Unkown | |
| HY-146516 | Anticancer agent 42 | / | Unkown | |
| HY-146676 | UR-MB108 | Inhibitor | / | Unkown |
| HY-146783 | ZINC194100678 | Inhibitor | / | Unkown |
| HY-146786 | ZMF-10 | / | Unkown | |
| HY-147101 | SK-575-NEG | Inhibitor | / | Unkown |
| HY-147556 | SK3 Channel-IN-1 | Modulator | / | Unkown |
| HY-147670 | TPB15 | / | Unkown | |
| HY-149033 | Kobusine derivative-2 | / | Unkown | |
| HY-149354 | Aurora kinase-IN-4 | Inhibitor | / | Unkown |
| HY-149388 | Anticancer agent 139 | Inhibitor | / | Unkown |
| HY-149635 | HIF-1α-IN-6 | Inhibitor | / | Unkown |
| HY-149729 | ICMT-IN-53 | Inhibitor | / | Unkown |
| HY-150597 | HDAC-IN-46 | / | Unkown | |
| HY-150613 | PARP1/BRD4-IN-2 | / | Unkown | |
| HY-151390 | hMAO-B/MB-COMT-IN-2 | Inhibitor | / | Unkown |
| HY-151630 | hCAIX-IN-16 | Inhibitor | / | Unkown |
| HY-152945 | Antiproliferative agent-22 | Inhibitor | / | Unkown |
| HY-153272 | Antitumor agent-93 | / | Unkown | |
| HY-155011 | MB076 | Inhibitor | / | Unkown |
| HY-155039 | Antitumor agent-105 | / | Unkown | |
| HY-155098 | CNBCA | Inhibitor | / | Unkown |
| HY-155127 | Antiproliferative agent-33 | Inhibitor | / | Unkown |
| HY-155146 | Anticancer agent 146 | Inducer | / | Unkown |
| HY-155180 | FD2056 | Inhibitor | / | Unkown |
| HY-155249 | KGP591 | Inhibitor | / | Unkown |
| HY-155350 | Tubulin polymerization-IN-53 | Inhibitor | / | Unkown |
| HY-155359 | Tubulin polymerization-IN-55 | Inhibitor | 98.84% | Unkown |
| HY-155766 | PARP1-IN-14 | / | Unkown | |
| HY-155949 | Bt354 | / | Unkown | |
| HY-155965 | VEGFR/PARP-IN-1 | / | Unkown | |
| HY-155969 | EGFR-IN-83 | / | Unkown | |
| HY-156018 | PI3Kα-IN-13 | Inhibitor | / | Unkown |
| HY-156026 | FAK-IN-11 | Inhibitor | / | Unkown |
| HY-156077 | anti-TNBC agent-2 | Inhibitor | / | Unkown |
| HY-156097 | Anticancer agent 158 | Inhibitor | / | Unkown |
| HY-156098 | c-Met-IN-19 | Inhibitor | / | Unkown |
| HY-156296 | CDK9-Cyclin T1 PPI-IN-1 | / | Unkown | |
| HY-156378 | Aurora A inhibitor 3 | Inhibitor | / | Unkown |
| HY-156402 | AuM1Gly | Inhibitor | / | Unkown |
| HY-156444 | HDAC1/CDK7-IN-1 | / | Unkown | |
| HY-156524 | USP1-IN-5 | Inhibitor | / | Unkown |
| HY-156525 | USP1-IN-6 | Inhibitor | / | Unkown |
| HY-15668 | ST09 | / | Unkown | |
| HY-157151 | iPRMT1 | Inhibitor | / | Unkown |
| HY-157210 | CDK7-IN-26 | Inhibitor | / | Unkown |
| HY-158387 | Anticancer agent 214 | Inhibitor | / | Unkown |
| HY-158388 | Anticancer agent 215 | Inhibitor | / | Unkown |
| HY-158389 | Anticancer agent 216 | Inhibitor | / | Unkown |
| HY-158390 | Anticancer agent 217 | Inhibitor | / | Unkown |
| HY-158439 | anti-TNBC agent-7 | Modulator | / | Unkown |
| HY-158683 | KIF18A-IN-11 | Inhibitor | / | Unkown |
| HY-159119 | hDHODH-IN-15 | / | Unkown | |
| HY-159122 | CA IX-IN-2 | / | Unkown | |
| HY-159515 | PBE-AMF | / | Unkown | |
| HY-159576 | O-Me Eribulin | / | Unkown | |
| HY-159897 | PAK4-IN-5 | / | Unkown | |
| HY-160598 | Exatecan-amide-bicyclo[1.1.1]pentan-1-ylmethanol | Inhibitor | / | Unkown |
| HY-160682 | EGFR/HER2-IN-12 | Inhibitor | / | Unkown |
| HY-161151 | RecQ helicase-IN-1 | / | Unkown | |
| HY-161257 | CDC20-IN-1 | Inducer | / | Unkown |
| HY-161372 | PARP1/c-Met-IN-1 | / | Unkown | |
| HY-161447 | USP1-IN-8 | Inhibitor | / | Unkown |
| HY-161517 | PARP1-IN-20 | Inhibitor | / | Unkown |
| HY-161687 | Cisplatin/Dasatinib prodrug-1 | Inhibitor | / | Unkown |
| HY-161755 | Anticancer agent 232 | / | Unkown | |
| HY-161769 | HL435 | / | Unkown | |
| HY-161770 | HL389 | / | Unkown | |
| HY-161778 | ZG-126 | / | Unkown | |
| HY-161855 | VEGFR-2-IN-50 | / | Unkown | |
| HY-161868 | DLC-50 | / | Unkown | |
| HY-161878 | USP1-IN-10 | Inhibitor | / | Unkown |
| HY-161995 | FGFR1/VEGFR2-IN-2 | / | Unkown | |
| HY-162012 | HC-258 | / | Unkown | |
| HY-162034 | FAK-IN-17 | Inhibitor | / | Unkown |
| HY-162046 | Anticancer agent 178 | Inducer | / | Unkown |
| HY-162532 | KIF18A-IN-10 | Inhibitor | / | Unkown |
| HY-162575 | Anticancer agent 231 | / | Unkown | |
| HY-162633 | USP1-IN-9 | / | Unkown | |
| HY-162643 | Antitumor agent-169 | Inhibitor | / | Unkown |
| HY-162688 | Anticancer agent 239 | Inducer | / | Unkown |
| HY-162751 | Anticancer agent 249 | / | Unkown | |
| HY-162805 | iNOS/TopoI-IN-1 | Inhibitor | / | Unkown |
| HY-162826 | Apoptosis inducer 27 | Inducer | / | Unkown |
| HY-162868 | c-Met/HDAC-IN-4 | / | Unkown | |
| HY-16308 | FBPase-IN-5 | Inhibitor | 99.31% | Unkown |
| HY-16311 | Zefoscytarabine | Inhibitor | / | Unkown |
| HY-163112 | Anticancer agent 179 | / | Unkown | |
| HY-163113 | Anticancer agent 180 | / | Unkown | |
| HY-163369 | HDAC6-IN-35 | Inhibitor | / | Unkown |
| HY-163434 | PRMT5/EGFR-IN-1 | Inhibitor | / | Unkown |
| HY-163760 | ZM-32 | Inhibitor | / | Unkown |
| HY-163845 | YX862 | Degrader | / | Unkown |
| HY-164306 | PROTAC PARP1 degrader-2 | Degrader | / | Unkown |
| HY-164320 | Anticancer agent 245 | Inducer | / | Unkown |
| HY-164349 | WZ-2-033 | Inhibitor | / | Unkown |
| HY-164533 | STAT3-IN-33 | Inhibitor | / | Unkown |
| HY-168154 | COMT-IN-2 | Inhibitor | / | Unkown |
| HY-168650 | ROCK/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-168720 | Apoptosis inducer 32 | Inducer | / | Unkown |
| HY-168901 | Hck-IN-2 | Inhibitor | / | Unkown |
| HY-169382 | Melatonin-Tamoxifen Conjugate | Inhibitor | / | Unkown |
| HY-169408 | EGFR-IN-137 | / | Unkown | |
| HY-170552 | KC12 | Inhibitor | / | Unkown |
| HY-170921 | USP1-IN-11 | Activator | / | Unkown |
| HY-170946 | WR-S-462 | Inhibitor | / | Unkown |
| HY-170947 | Antitumor agent-195 | Inhibitor | / | Unkown |
| HY-170955 | HA-CD44 interaction inhibitor 3 | Inhibitor | / | Unkown |
| HY-170965 | Anticancer agent 264 | Inhibitor | / | Unkown |
| HY-171777 | Erufosine | Inhibitor | / | Unkown |
| HY-172092 | BG11 | Inducer | / | Unkown |
| HY-172115 | BGC4 | / | Unkown | |
| HY-172159 | FF2039 | Inhibitor | / | Unkown |
| HY-172551 | anti-TNBC agent-9 | / | Unkown | |
| HY-172886 | PI3K-IN-58 | / | Unkown | |
| HY-172888 | SPP-037 | Inhibitor | / | Unkown |
| HY-172891 | CDK9/HDAC1/HDAC3-IN-1 | Inhibitor | / | Unkown |
| HY-172957 | JNN-5 | Inhibitor | / | Unkown |
| HY-172966 | EG31 | Inhibitor | / | Unkown |
| HY-173060 | ERK1/2 inhibitor 13 | / | Unkown | |
| HY-173075 | Anticancer agent 267 | / | Unkown | |
| HY-173146 | EGFR-IN-153 | / | Unkown | |
| HY-173257 | Cath-L-dBET1 | Degrader | / | Unkown |
| HY-173296 | MAGL-IN-222 | Inhibitor | / | Unkown |
| HY-173498 | AR ligand 40 | Antagonist | / | Unkown |
| HY-174160 | MerTK-IN-2 | / | Unkown | |
| HY-174211 | JNK-IN-23 | Inhibitor | / | Unkown |
| HY-174232 | EGFR/CA-IX-IN-1 | / | Unkown | |
| HY-174248 | PS21M | Control | / | Unkown |
| HY-174306 | MARY1 | / | Unkown | |
| HY-174442 | PARP1-IN-40 | Inhibitor | / | Unkown |
| HY-174457 | STAT3/CAIX-IN-1 | / | Unkown | |
| HY-174828 | ATR/PARP1-IN-1 | / | Unkown | |
| HY-174992 | Apoptosis inducer 39 | Inducer | / | Unkown |
| HY-175004 | PBD dimer-4 | / | Unkown | |
| HY-175030 | TNI-97 | / | Unkown | |
| HY-175173 | EGFR-IN-166 | Inhibitor | / | Unkown |
| HY-175179 | LO-3-61 | Degrader | / | Unkown |
| HY-175269 | MGB1Y | Inhibitor | / | Unkown |
| HY-175466 | BER-IN-1 | / | Unkown | |
| HY-175497 | ROR1-IN-4 | / | Unkown | |
| HY-175544 | anti-TNBC agent-10 | / | Unkown | |
| HY-175638 | Carbonic anhydrase-IN-35 | / | Unkown | |
| HY-175815 | Apoptosis inducer 44 | / | Unkown | |
| HY-175821 | PRMT1-IN-3 | / | Unkown | |
| HY-175846 | TQFL13 | Inducer | / | Unkown |
| HY-175874 | Tubulin-IN-55 | / | Unkown | |
| HY-176147 | Apoptosis inducer 38 | Inducer | / | Unkown |
| HY-176220 | GPX4-AUTAC | / | Unkown | |
| HY-176431 | TLCD1-IN-1 | / | Unkown | |
| HY-176495 | SG3683 | / | Unkown | |
| HY-177270 | CHNQD-01281 | Modulator | / | Unkown |
| HY-177724 | GSPT1 degrader-11 | Degrader | / | Unkown |
| HY-178034 | PROTAC OSBP Degrader-1 | Degrader | / | Unkown |
| HY-178115 | MB-Buf | / | Unkown | |
| HY-178132 | Apoptosis inducer 46 | / | Unkown | |
| HY-178261 | KT53 | Inhibitor | / | Unkown |
| HY-178343 | Aurora A-IN-5 | / | Unkown | |
| HY-178365 | PAD-IN-4 | Inhibitor | / | Unkown |
| HY-178460 | BRK/PTK6-IN-1 | Inhibitor | / | Unkown |
| HY-178467 | PROTAC FAK degrader 4 | Degrader | / | Unkown |
| HY-178955 | EGFR-IN-182 | / | Unkown | |
| HY-178956 | KUNB106 | Inhibitor | / | Unkown |
| HY-178957 | Hsp90β-IN-2 | Inhibitor | / | Unkown |
| HY-179039 | EGFR-IN-183 | Inhibitor | / | Unkown |
| HY-179046 | VEGFR-2-IN-78 | Inhibitor | / | Unkown |
| HY-179054 | Apoptosis inducer 51 | / | Unkown | |
| HY-179062 | Anticancer agent 280 | Inducer | / | Unkown |
| HY-179070 | Anticancer agent 281 TFA | Inducer | / | Unkown |
| HY-179232 | ERα antagonist 2 | Antagonist | / | Unkown |
| HY-179372 | Tubulin polymerization-IN-84 | 99.59% | Unkown | |
| HY-179413 | Polθ-IN-9 | Inhibitor | / | Unkown |
| HY-179430 | TTK-IN-5 | Inhibitor | / | Unkown |
| HY-179468 | STAT3-IN-49 | Inhibitor | / | Unkown |
| HY-179535 | Axl-IN-21 | Inhibitor | / | Unkown |
| HY-179679 | FAK-IN-29 | / | Unkown | |
| HY-180195 | Grp94-IN-3 | Inhibitor | / | Unkown |
| HY-180814 | SKF-83566-PEG1-pomalidomide | Antagonist | / | Unkown |
| HY-180893 | XH-30 | / | Unkown | |
| HY-181583 | LASSBio-2389 | Inhibitor | / | Unkown |
| HY-183363 | USP1-IN-17 | Inhibitor | / | Unkown |
| HY-183618 | DW-229 | Degrader | / | Unkown |
| HY-183995 | SH-26 | / | Unkown | |
| HY-184650 | SHP2/NAMPT-IN-1 | / | Unkown | |
| HY-184697 | Anticancer agent 334 | / | Unkown | |
| HY-187347 | PROTAC NAMPT Degrader-31 | Degrader | / | Unkown |
| HY-187454 | PI3Kα/CDK7-IN-1 | / | Unkown | |
| HY-203817 | IITZ-02 | 96.51% | Unkown | |
| HY-D0312 | Mordant Blue 13 | / | Unkown | |
| HY-D3140 | MB-m-borate | / | Unkown | |
| HY-D3520 | HPsensor 2 | / | Unkown | |
| HY-N0448A | (±)-10-Gingerol | / | Unkown | |
| HY-N0448R | 10-Gingerol (Standard) | / | Unkown | |
| HY-N0985 | 1,4,5,6-Tetrahydroxy-7,8-diprenylxanthone | / | Unkown | |
| HY-N13118 | Sinopodophylline B | / | Unkown | |
| HY-N15636 | Coccinine | Inhibitor | / | Unkown |
| HY-N17494 | Crispene E | / | Unkown | |
| HY-N2741 | Vitexin B-1 | Inhibitor | / | Unkown |
| HY-N7484 | (−)-Voacangarine | Inhibitor | / | Unkown |
| HY-N7507 | Sempervirine | Inhibitor | / | Unkown |
| HY-P10511 | Pantinin-3 | / | Unkown | |
| HY-P10760 | PhAc-ALGP-Dox | / | Unkown | |
| HY-P10790 | Breast cancer targeting peptide 18–4 | Inhibitor | / | Unkown |
| HY-P10853 | Bacilotetrin C analogue | Inducer | / | Unkown |
| HY-P10873 | ST-CY14 | / | Unkown | |
| HY-RS08179 | MB Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS08180 | MB21D2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00002A | ZD-4190 hydrochloride | Inhibitor | / | Unkown |
| HY-W072781 | N-Deacetylthiocolchicine | Inhibitor | / | Unkown |
| HY-W1117786 | Nampt-IN-10 | Inhibitor | / | Unkown |
| HY-116904 | Anticancer agent 253 | / | Unkown | |
| HY-119948 | AKCI | Modulator | / | Unkown |
| HY-131764 | 2'-O-MB-cGMP sodium | Inhibitor | / | Unkown |
| HY-134997 | 4-Oxo Docosahexaenoic Acid | Agonist | / | Unkown |
| HY-137866 | Tubulin inhibitor 9 | Inhibitor | / | Unkown |
| HY-138210 | N,O-Diacetyltyramine | Inhibitor | / | Unkown |
| HY-139795 | ZYJ-25e | Inhibitor | / | Unkown |
| HY-139815 | ZYJ-34c | Inhibitor | / | Unkown |
| HY-14955A | (Rac)-Managlinat dialanetil | / | Unkown | |
| HY-149710 | POP-3MB | Inhibitor | / | Unkown |
| HY-149714 | J6-3 | Inhibitor | / | Unkown |
| HY-149715 | R1-11 | Inhibitor | / | Unkown |
| HY-160121 | Patrinoside aglucone | Inhibitor | / | Unkown |
| HY-161118 | MB327 | / | Unkown | |
| HY-161773 | HL389-NHC2-PEG3-C2NH | / | Unkown | |
| HY-164500 | MC3629 | Inhibitor | / | Unkown |
| HY-164521 | PMMB-187 | Inhibitor | / | Unkown |
| HY-165615 | M&B 4935 | Inhibitor | / | Unkown |
| HY-168326 | Antiproliferative agent-64 | Inhibitor | / | Unkown |
| HY-170527 | Anticancer agent 260 | / | Unkown | |
| HY-171477 | Metahexestrol | Ligand | / | Unkown |
| HY-177966 | ETM-305 | / | Unkown | |
| HY-182621 | MB4253 | Inhibitor | / | Unkown |
| HY-183197 | SR 13915 | / | Unkown | |
| HY-183416 | M&B 39279 | Inhibitor | / | Unkown |
| HY-184485 | MB-32 | Inhibitor | / | Unkown |
| HY-187163 | Anticancer agent 355 | Degrader | / | Unkown |
| HY-D2741 | MB 488 NHS ester | / | Unkown | |
| HY-D2767 | MB 660R NHS Ester | / | Unkown | |
| HY-N13163 | 2-Epitripdiolide | / | Unkown | |
| HY-P10393 | ERα17p | Inducer | / | Unkown |
| HY-RS16688 | Mb Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23123 | Mb Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010713 | Meso-tetraphenylchlorin | / | Unkown | |
| HY-W369099 | HJC0152 free base | 98.30% | Unkown | |
| HY-W583350 | Chloro(triphenylphosphine) [2-(2'-amino-1,1'-biphenyl)]palladium(II) | Inducer | / | Unkown |
| HY-W667666 | Anthragallol 1,2-dimethyl ether | / | Unkown | |
| HY-W800770 | MB 543 DBCO | / | Unkown | |
| HY-W800832 | MB 660R DBCO | / | Unkown |
Inhibitory Antibodies
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990806 | Anti-Mouse CD20 Antibody (MB20-11) | Inhibitor | 98.79% | Unkown |
| HY-P990267 | Anti-Mouse CD45RB Antibody (MB23G2) | Inhibitor | / | Unkown |
| HY-P990622 | MB-311 | Inhibitor | / | Unkown |
| HY-P991328 | MAb604.107 | Inhibitor | / | Unkown |
| HY-P991370 | SBT-100 (His Tag) | Inhibitor | / | Unkown |
| HY-P991426 | MB-314 | / | Unkown | |
| HY-P990823 | Anti-Mouse PD-L1/B7-H1 Antibody (10F.2H11) | Inhibitor | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service